"Longs On the Wrong Side"
By Jim Cramer
RealMoney.com Columnist
1/3/2008 8:03 AM EST
" The longs are just on the wrong side right now. When you get that kind of opening, at the beginning of the year, where everyone who buys anything is wrong and losing money, and funds are down a percent to two percent from the get go, you get very dispirited.
But that's the way of a market with nothing going for it right now. That's right, nothing.
I read many of the pieces that came out yesterday about things that are happening, good earnings, good profits, good buybacks. But I found myself thinking that the only things I want to buy are really beaten-up internationally oriented techs and really beaten-up health-care stocks, with the idea that inflation isn't raging and the economy's slowing enough to make the CVS' (CVS - commentary - Cramer's Take - Rating) and the Mercks (MRK - commentary - Cramer's Take - Rating) and the Scherings (SGP - commentary - Cramer's Take - Rating) look good.
Instead, I got my head handed to me.
I know that the total focus for everyone is on the financials. "Is Citigroup (C - commentary - Cramer's Take - Rating) a buy?" I heard a gazillion times yesterday.
To me the question is: can I buy healthcare. The growth will be there. The consistency will be there.
But the gold price is killing the Medco (MHS - commentary - Cramer's Take - Rating) multiple, shorthand for we are not going to pay a lot of money in the out years for decent consistent growth.
Now, all of that said, remember there was a lot of prop up. We are seeing the unwinding of that prop up, and we are going to be oversold soon. Nasdaq's been down for four straight days -- hence why I wanted to look at beat-up international tech, Microsoft/Intel -- and we get rid of Iowa and employment uncertainty in the next 24 hours.
To me, sitting tight, making small picks for health care and tech, they will do it for me.
And oil and gold? Just stay in 'em.
At the time of publication, Cramer was long C, CVS and SGP.
(in
www.realmoney.com)
Disclosure: Os meus clientes possuem posições longas sobre a MHS